Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers

S A J Vaziri¹, R R Tubbs², G Darlington³ and G Casey¹

¹ Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA
² Department of Clinical Pathology, Cleveland Clinic Foundation
³ Department of Mathematics and Statistics, University of Guelph, Guelph, Ontario, N1G-2X5, Canada

Correspondence to:
Dr Casey caseyg{at}ccf.org

Background/Aims—It was recently reported that significantly fewer breast tumours of BRCA1 mutation carriers overexpressed cyclin D1 and HER2 protein than tumours of age matched breast cancer cases unselected for family history. This study aimed to examine the genetic basis of this reduction by determining the frequency of tumours within this cohort showing DNA amplification of these genes.

Methods—Paraffin wax embedded sections of breast tumours from BRCA1 mutation carriers and age, grade, histological type, and tumour size matched non-familial controls that had previously been stained for cyclin D1 and HER2 protein overexpression were analysed for CCND1 and HER2 gene amplification using fluorescence in situ hybridisation.

Results—CCND1 amplification was detected in none of the 30 tumours of the BRCA1 mutation carriers and in 19 of 74 tumours of the matched controls. Of those samples previously determined to overexpress the HER2 protein, HER2 amplification was detected in one of three tumours from BRCA1 mutation carriers and in 13 of 17 tumours of the age matched non-familial cases.

Conclusion—None of the tumours of BRCA1 mutation carriers showed CCND1 amplification and only one tumour showed HER2 amplification. In contrast, a large proportion of cyclin D1 and HER2 overexpression in tumours of non-familial breast cancer cases could be accounted for by amplification of these genes. These data suggest that breast tumorigenesis in BRCA1 mutation carriers occurs by a molecular mechanism distinct from that of age matched non-familial cases.

Key Words: CCND1 • HER2 • BRCA1

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Tan, D S P, Marchio, C, Reis-Filho, J S (2008). Hereditary breast cancer: from molecular pathology to tailored therapies. J. Clin. Pathol. 61: 1073-1082 [Abstract] [Full Text]  
• Parry, S, Savage, K, Marchio, C, Reis-Filho, J S (2008). Nestin is expressed in basal-like and triple negative breast cancers. J. Clin. Pathol. 61: 1045-1050 [Abstract] [Full Text]  
• Yarden, R. I., Papa, M. Z. (2006). BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions.. Molecular Cancer Therapeutics 5: 1396-1404 [Abstract] [Full Text]  
• Rosen, E M, Fan, S, Isaacs, C (2005). BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocr Relat Cancer 12: 533-548 [Abstract] [Full Text]  
• Chunder, N., Mandal, S., Roy, A., Roychoudhury, S., Panda, C. K. (2004). Differential Association of BRCA1 and BRCA2 Genes with Some Breast Cancer-Associated Genes in Early and Late Onset Breast Tumors. Ann. Surg. Oncol. 11: 1045-1055 [Abstract] [Full Text]  
• Jongsma, A P M, Piek, J M J, Zweemer, R P, Verheijen, R H M, Klein Gebbinck, J W T, van Kamp, G J, Jacobs, I J, Shaw, P, van Diest, P J, Kenemans, P (2002). Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. Mol. Pathol. 55: 305-309 [Abstract] [Full Text]  
• Sinclair, C. S., Adem, C., Naderi, A., Soderberg, C. L., Johnson, M., Wadum, L., Couch, V. L., Sellers, T. A., Schaid, D., Slezak, J., Fredericksen, Z., Ingle, J. N., Hartmann, L., Jenkins, R. B., Couch, F. J. (2002). TBX2 Is Preferentially Amplified in BRCA1- and BRCA2-related Breast Tumors. Cancer Res. 62: 3587-3591 [Abstract] [Full Text]  
• Welcsh, P. L., Lee, M. K., Gonzalez-Hernandez, R. M., Black, D. J., Mahadevappa, M., Swisher, E. M., Warrington, J. A., King, M.-C. (2002). BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc. Natl. Acad. Sci. USA 99: 7560-7565 [Abstract] [Full Text]